A review article summarizing research results from the discovery of thalidomide’s intracellular target cereblon (CRBN) to the latest research results has been published in Chemical Society Reviews (IF=60.615). The first author of the article is Assistant Professor Yamamoto, co-authored with Dr. Handa and Dr. Ito of Tokyo Medical University.
https://pubs.rsc.org/en/content/articlepdf/2022/CS/D2CS00116K